PapersPMID:23675006
Hormone-Balancing Effect of Pre-Gelatinized Organic Maca (Lepidium peruvianum Chacon): (III) Clinical responses of early-postmenopausal women to Maca in double blind, randomized, Placebo-controlled, crossover configuration, outpatient study.
- findings
- 2
- compound
- 1
- endpoints
- 2
- Study, every finding
- crossover · 2 months
- Dose studied, every finding
- Two 500 mg capsules twice daily with meals, total 2 g/day, for two months in the maca period
- Population, every finding
- Early-postmenopausal Caucasian women aged 49 to 58 years (E2 under 40 pg/mL, FSH over 30 IU/mL), randomised crossover of placebo and Maca-GO sequences; overall effect across both sequences
No finding here moved its endpoint.
What did not
How to read these marks →“Table 4 which summarizes lipid and mineral metabolism data, shows that the overall effect of Maca-GO on Cholesterol, Triglycerides and HDL in relation to overall Placebo effect was statistically not significant (P>0.05).”
- Interests
- Industry funded
- Interests
- Industry funded
Study record
- Design
- crossover trial
- Species
- human
- Population
- Caucasian early-postmenopausal women in good health (FSH 30 IU/mL or more, E2 40 pg/mL or less); pre-gelatinized organic maca (Maca-GO, Lepidium peruvianum Chacon) versus placebo in sequence A-P-P-M-M or A-M-M-P-P; 22 in the crossover trial and 12 in a forearm bone density observation
- Participants
- 34
- Comparator
- placebo
- Duration
- 122 days
- Endpoints measured
- 67